T1	intervention 67 75	flaxseed
T2	condition 97 108	hot flashes
T3	eligibility 413 463	Postmenopausal women with or without breast cancer
T4	control 556 567	placebo bar
T5	outcome-Measure 748 842	intraparticipant difference in hot flash activity between baseline and the last treatment week
T6	total-participants 981 984	188
T8	iv-cont-mean 1057 1060	4.9
T9	cv-cont-mean 1087 1090	3.5
T10	outcome 1195 1229	reduction in their hot flash score
T11	outcome 1299 1315	grade 1 pruritus
T12	cv-bin-percent 1361 1363	8%
T13	iv-bin-percent 1367 1369	1%
T14	outcome 1393 1413	abdominal distension
T15	outcome 1415 1425	flatulence
T16	outcome 1427 1435	diarrhea
T17	outcome 1441 1447	nausea
T18	outcome 1449 1501	Adherence and ability to detect treatment assignment
T7	outcome 1024 1044	mean hot flash score
